Cresset Asset Management, LLC Morpho Sys Ag Transaction History

Cresset Asset Management, LLC

  • $25.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$5.87 - $9.73 $208,420 - $345,473
-35,506 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$9.08 - $12.45 $128,291 - $175,906
14,129 Added 66.09%
35,506 $334,000
Q3 2021

Nov 15, 2021
BUY
$11.76 - $19.51 $110,790 - $183,803
9,421 Added 78.8%
21,377 $252,000
Q2 2021

Aug 10, 2021
BUY
$18.95 - $23.95 $226,566 - $286,346
11,956 New
11,956 $230,000

Others Institutions Holding MOR

# of Institutions
13
Shares Held
1.8M
Call Options Held
0
Put Options Held
14.7K
View Full List

About MorphoSys AG

MOR Quotes by TradingView
  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email